Attovia Therapeutics (ATTO) Stock Price, News & Analysis
Company Description
Attovia Therapeutics (NASDAQ: ATTO) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $890.7M, ranking #3,067 among all listed U.S. companies by market cap.
ATTO has gained 10349900.0% over the past year. Shares last traded at $20.70.
This page collects what Stock Titan holds for ATTO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Attovia Therapeutics (ATTO) stock last closed at $20.70. Over the past 12 months, the stock has gained 10349900.0%. At a market capitalization of $890.7M, ATTO is classified as a small-cap stock with approximately 43.0M shares outstanding.
ATTO Rankings
Latest News
Attovia Therapeutics has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include IPO, offering. View all ATTO news →
SEC Filings
Attovia Therapeutics has filed 5 recent SEC filings, including 2 Form 4, 2 Form 4/A, 1 Form 144. The most recent filing was submitted on August 28, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ATTO SEC filings →
Insider Radar
Insider buying activity at Attovia Therapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ATTO Company Profile & Sector Positioning
Attovia Therapeutics (ATTO) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.